Cargando…

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes

High-grade serous ovarian carcinoma (HGSOC) has a significant hereditary component, approximately half of which cannot be explained by known genes. To discover genes, we analyse germline exome sequencing data from 516 BRCA1/2-negative women with HGSOC, focusing on genes enriched with rare, protein-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subramanian, Deepak N., Zethoven, Magnus, McInerny, Simone, Morgan, James A., Rowley, Simone M., Lee, Jue Er Amanda, Li, Na, Gorringe, Kylie L., James, Paul A., Campbell, Ian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118163/ https://www.ncbi.nlm.nih.gov/pubmed/32242007 http://dx.doi.org/10.1038/s41467-020-15461-z

Ejemplares similares

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
por: Li, Na, et al.
Publicado: (2018)

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study
por: Li, Na, et al.
Publicado: (2021)

Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants
por: Lim, Belle W X, et al.
Publicado: (2022)

Integration of tumour sequencing and case–control data to assess pathogenicity of RAD51C missense variants in familial breast cancer
por: Lim, Belle W. X., et al.
Publicado: (2022)

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything
por: Kader, Tanjina, et al.
Publicado: (2022)

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context
por: Thompson, Ella R., et al.
Publicado: (2015)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
por: Thompson, Ella R., et al.
Publicado: (2015)

Cell cycle regulated transcription: from yeast to cancer
por: McInerny, Christopher J.
Publicado: (2016)

Ten Simple Rules for Curating and Facilitating Small Workshops
por: McInerny, Greg J.
Publicado: (2016)

52 degrees south: mental health services in the Falkland Islands
por: Rimicans, Karen, et al.
Publicado: (2018)

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
por: Cooke, Susanna L, et al.
Publicado: (2010)

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
por: Azzalini, Eros, et al.
Publicado: (2023)

ESCRT Function in Cytokinesis: Location, Dynamics and Regulation by Mitotic Kinases
por: Bhutta, Musab S., et al.
Publicado: (2014)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
por: Schwarz, Roland F., et al.
Publicado: (2015)

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
por: Cheasley, Dane, et al.
Publicado: (2022)

A Complex Network of Interactions between Mitotic Kinases, Phosphatases and ESCRT Proteins Regulates Septation and Membrane Trafficking in S. pombe
por: Bhutta, Musab S., et al.
Publicado: (2014)

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
por: Hao, Qian, et al.
Publicado: (2021)

The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
por: Kader, Tanjina, et al.
Publicado: (2020)

The Number of Candidate Variants in Exome Sequencing for Mendelian Disease under No Genetic Heterogeneity
por: Nishino, Jo, et al.
Publicado: (2013)

Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer
por: Xiang, Li, et al.
Publicado: (2018)

Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer
por: Lu, Haonan, et al.
Publicado: (2021)

Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene
por: Dicks, Ed, et al.
Publicado: (2017)

Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Exome sequencing in patients with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects
por: Li, Na, et al.
Publicado: (2021)

Folate receptor targeted nanoparticles containing niraparib and doxorubicin as a potential candidate for the treatment of high grade serous ovarian cancer
por: Wang, Lucy, et al.
Publicado: (2023)

Anillin/Mid1p interacts with the ESCRT-associated protein Vps4p and mitotic kinases to regulate cytokinesis in fission yeast
por: Rezig, Imane M., et al.
Publicado: (2021)

The role of anillin/Mid1p during medial division and cytokinesis: from fission yeast to cancer cells
por: Rezig, Imane M., et al.
Publicado: (2022)

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
por: Lung, Mei Sim, et al.
Publicado: (2020)

Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma
por: de Cristofaro, Tiziana, et al.
Publicado: (2016)

Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2023)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression
por: Mota, Alba, et al.
Publicado: (2015)

Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity
por: Sun, Tingting, et al.
Publicado: (2022)

KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
por: De Donato, Marta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6c617gg919qnmo41hr3qsm8gud